CHORMAN THOMAS E sold $15K of SXI
CHORMAN THOMAS E sold 50 shares of STANDEX INTERNATIONAL CORP/DE/ (SXI) at $305.56 on 2026-08-03 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the director’s open-market sale of 50 shares at $305.56 on 2026-08-03, with a stated pre-arranged 10b5-1 plan.
Market read
This is a routine insider-sale disclosure with limited trading implications due to the small value and 10b5-1 pre-arrangement.
What to watch
The filing does not indicate whether other insiders sold/bought around the same time, nor does it provide context on total holdings changes beyond the post-transaction share count.
Background
The article is an SEC Form 4 insider transaction disclosure for STANDEX INTERNATIONAL CORP/DE (SXI).
Ticker impact
STANDEX INTERNATIONAL CORP/DE (SXI) disclosed a director open-market sale of 50 shares at $305.56 on 2026-08-03 via Form 4.
Likely limited immediate price impact; any reaction should be muted given the pre-arranged 10b5-1 context and small size.
The filing is a primary-source insider transaction, but the disclosed trade size ($15.3k) is modest and explicitly tied to a pre-arranged 10b5-1 plan, reducing interpretive weight.
Market effects
No sector-level implications; this is company-specific insider dealing.
None indicated.
None indicated.
Counterpoint
Even with a 10b5-1 plan, repeated or larger-than-usual insider selling can still reflect management’s risk management rather than a fundamental deterioration.
Key entities
- issuerSTANDEX INTERNATIONAL CORP/DE
Subject of the Form 4 insider transaction disclosure (SXI).
- insiderCHORMAN THOMAS E
Director who sold 50 shares in an open-market transaction under a 10b5-1 plan.
